N-ACETYLCYSTEINE REDUCES VON WILLEBRAND FACTOR MULTIMER SIZE AND IMPROVES RENAL MICROVASCULAR BLOOD FLOW IN RATS AFTER SEVERE TRAUMA.
Level 5 - mechanism / opinion, no new human data
Bench/animal study (rat polytrauma model)
PubMed 40333203 · doi:10.1097/SHK.0000000000002611
What was done
Anesthetized male Sprague-Dawley rats were subjected to standardized polytrauma and pressure-targeted catheter hemorrhage. Animals were allocated to receive either no treatment (control) or a single bolus of N-acetylcysteine (NAC), followed by autologous whole blood transfusion. Renal microvascular blood flow (MBF) was evaluated using contrast-enhanced ultrasound at prespecified time points. Laboratory analyses included von Willebrand factor (VWF) multimer gel electrophoresis, and histological analysis of vascular thrombi was performed on uninjured tissue from trauma versus sham-operated rats.
What was found
The abstract reports no numerical values, effect sizes, or p-values. NAC administration was reported to increase renal MBF at 3 hours after resuscitation relative to controls. This improvement was accompanied by a reduction in VWF multimer size that was absent in the control group. Histological analysis showed an overall increase in systemic thrombus burden associated with trauma.
Why it matters
Microvascular hypoperfusion often persists despite macrovascular blood pressure normalization following severe trauma. These findings suggest that targeting hyperadhesive VWF multimers with NAC may help alleviate microthrombus burden and improve vital organ microvascular perfusion.
Limits
This is an animal model in anesthetized male rats, limiting translation to human trauma resuscitation. The abstract does not report the sample size (n), drug dosage, baseline characteristics, exact flow measurements, or statistical significance metrics. Follow-up was restricted to 3 hours post-resuscitation, leaving long-term organ function, bleeding risks, and survival unmeasured.
Cited by
- supports N-acetylcysteine (NAC) inhibits von Willebrand factor to prevent microclots.